期刊文献+

先心病肺动脉高压与血管紧张素Ⅱ的关系研究 被引量:1

Fluctuation of Angiotension n levels in patients with congenital disease associated with pulmonary hypertension pre-and post- interventional therapy
下载PDF
导出
摘要 目的观察先天性心脏病(简称先心病)介入封堵术前后血浆血管紧张素Ⅱ(AngⅡ)的浓度变化,探讨其在先心病肺动脉高压(PH)中的作用及其临床意义。方法选取70例先心病患者,其中房间隔缺损30例、室间隔缺损30例、动脉导管未闭10例,依据心导管测压分为无PH组(20例)、轻度PH组(30例)和中重度PH组(20例)。分别用放射免疫法测定各组患者术前和术后24h、1个月、3个月、6个月血浆AngⅡ浓度。另选取年龄及性别与之相匹配的正常体检儿童30例作为对照组。结果术前先心病伴PH组患者血浆AngⅡ水平明显高于无PH组(P<0.01)。先心病有、无PH 患者介入封堵术后24h,AngⅡ开始缓慢下降,至6个月基本下降到正常水平(P<0.01)。术前血浆AngⅡ浓度与肺动脉压力呈显著正相关(r=0.715,P<0.05)。结论 AngⅡ可能参与了先心病PH的发生、发展过程。 Objective To observe the concentration changes of angiotension Ⅱ (Ang Ⅱ ) levels in congenital heart disease (CHD) before and after interventional therapy, and explore its role in CHI) associated with pulmonary hjpertension (PH). Methods Seventy patients with CHD were enrolled in this study, of which thirty with atrial septal defects, thirty with ventricular septal defects, and ten with patent arterial duct. According to patients associated with or without PH, all the patients were allocated to an absent PH group ( n =20), a mild PH group ( n = 30) and a moderate-severe PH group ( n = 20). A radiolmmunoasay was used to detect the concentration levels of Ang Ⅱ in the above three groups before interventional therapy, and at 24 hours, 1 month, 3 months, 6 months after interventional therapy. Thirty healthy children of the control group were enrolled in this study. Results In patients with CHD associated with PH before interventional therapy, the Ang Ⅱ levels were significantly higher than those in patients without PH ( P 〈 0.01). In patients with CHD associated with or without PH, 24 hours after interventional therapy, the Ang Ⅱ levels began to slowly decrease, and till the sixth months, it recovered to normal levels ( P 〈 0.01). Before interventional therapy, the plasma Ang Ⅱ concentration had significantly positive correlation to pulmonary tension ( r = 0.715, P 〈0.05). Conclusion AngⅡ may play an important role in the pathogenesis of CHK) associated with PH.
机构地区 广西医科大学
出处 《右江民族医学院学报》 2006年第1期10-12,共3页 Journal of Youjiang Medical University for Nationalities
基金 广西科技攻关项目(桂科攻0472002-30)
关键词 心脏病/先天性 高血压 肺性 血管紧张素Ⅱ 方差分析 heart diseases/congenital hypertension, pulmonary angiotension Ⅱ analysis of variance
  • 相关文献

参考文献8

  • 1Hoch M, Netz H. Heart failure in pediatric patients [J].Thorac Cardlovasc Surg,2005,53 (Suppl 2):129-134.
  • 2Ohuchi H, Suzuki H, Toyohara K, et al. Abnormal cardiac autonomic nervous activity after right ventricular outflow tract reconstruction [J]. Circulation,2000,102(22) :2732-2738.
  • 3Ohuchi H, Takasugi H, Ohashi H, et al. Abnormaloties of neurohormonal and cardiac autonomic nervous aetivities relate poorly to functional status in fontan patients [J]. Circulation,2004,110(17) :2601 - 2608.
  • 4Jackson RM, Naxkates AJ, Oparil S. Impaired pulmonary conversion of angiotensin Ⅰ to angiotensin Ⅱ in rats exposed to chronic hypoxia [J]. J Appl Physiol, 1986,60(4): 1121-1127.
  • 5Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease [J]. Circulation, 2002,106(1) : 92-99.
  • 6李爱萍,陈光辉,李天德,刘航,易军,王莉.不同水平干预对AngII作用心肌细胞活力的影响[J].军医进修学院学报,2004,25(4):252-254. 被引量:8
  • 7Dietz R, yon - Harsdorf R, Gross M, et al. Anglotensin Ⅱ and coronary artery disease, congestive heart failure and sudden cardiac death [ J ]. Basic Res Cariol, 1998, 93 (suppl 2) : sl01 - 108.
  • 8Chung O, Csikos T,Unger T. AngiotensinⅡ receptor pharmacology and AT2 receptors [J ]. J Hum Hypertens, 1999,12(suppl 1) :S11 - 20.

二级参考文献9

  • 1Wei C, Cardarelli MG, Downing SW, et al. The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes[J]. J Renin Angiotensin Aldos- terone Syst, 2000,1(4):379-84.
  • 2Simpson DG, Decker ML, Clark WA, et al. Contractile activity and cell-cell contact regulate myofibrillar organization in cultured cardiac myocytes[J].J Cell Biol,1993,123(2):323-336.
  • 3Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays[J].J Immunol Methods,1983,65(1-2):55-63.
  • 4Freimoser FM, Jakob CA, Aebi M, et al.The MTT [3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities[J], Appl Environ Microbiol,1999,65:3727-3729.
  • 5Matsubara H.Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases[J]. Circ Res,1998, 83 (12): 1182-1191.
  • 6Matsubara H, Iwasaka T. Angiotensin II receptor-mediated function un- masked by gene-engineered animals[J].Nippon Rinsho,1999,57(5):1084-1089.
  • 7Pellieux C, Sauthier T, Aubert JF,et al. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen- activated protein kinase activation in normotensive and hypertensive mice[J]. J Hypertens,2000,18(9):1307-1317.
  • 8Morii I, Kihara Y, Inoko M, et al.Myocardial contractile efficiency and oxygen cost of contractility are preserved during transition from compensated hypertrophy to failure in rats with salt-sensitive hypertension[J].Hypertension,1998,31(4):949-960.
  • 9Gaballa MA, Goldman S. Ventricular remodeling in heart failure[J].J Card Fail,2002,8(6 Suppl):S476-485.

共引文献7

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部